Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2003
05/15/2003WO2003040398A2 Proteins stabilized with polysaccharide gums
05/15/2003WO2003040308A2 Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo
05/15/2003WO2003040138A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040136A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040135A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040073A1 Alkyl(en)ylglycerinether carboxylic acids
05/15/2003WO2003039729A1 Method for the production of particles
05/15/2003WO2003039727A2 Apparatus and method for manufacturing encapsulated products
05/15/2003WO2003039724A1 Multiple emulsions comprising particles of nanometric dimensions with modified surface as stabilizing agents
05/15/2003WO2003039677A2 Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
05/15/2003WO2003039615A2 Porous polymeric prostheses and methods for making same
05/15/2003WO2003039597A1 Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
05/15/2003WO2003039596A1 Photodynamic therapy for the treatment of hair loss
05/15/2003WO2003039595A2 Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
05/15/2003WO2003039577A1 Remedies for dry eye and diseases associated with dry eye
05/15/2003WO2003039570A1 Composition containing an extract of pericarpium zanthoxyli for protecting brain cells and improving memory
05/15/2003WO2003039569A1 Process for the preparation of anthocyanin-containaing products
05/15/2003WO2003039566A2 Methods of treatment in situ in the lungs of mammals
05/15/2003WO2003039564A1 Selective targeting of apoptotic cells
05/15/2003WO2003039561A1 Pharmaceutical composition
05/15/2003WO2003039553A1 Compositions for treatment of postmenopausal female sexual dysfunction
05/15/2003WO2003039546A1 New uses for anti-malarial therapeutic agents
05/15/2003WO2003039532A1 Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
05/15/2003WO2003039531A1 Modified release tamsulosin tablets
05/15/2003WO2003039530A1 Tamsulosin tablets
05/15/2003WO2003039527A1 Controlled release tablets of metformin
05/15/2003WO2003039524A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
05/15/2003WO2003039523A2 OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
05/15/2003WO2003039522A1 Surface coated capsules
05/15/2003WO2003039521A1 Solid, stabilized, prompt- and/or modified-release therapeutical systems for the oral administration of liquid active principles, excipients or foodstuffs
05/15/2003WO2003039520A1 Orodispersible tablet having high homogeneity and the preparation method thereof
05/15/2003WO2003039519A2 Dual controlled release dosage form
05/15/2003WO2003039518A1 Oral controlled release forms useful for reducing or preventing nicotine cravings
05/15/2003WO2003039517A1 Process for preparing quick dissolving, high loading ribavirin compositions
05/15/2003WO2003039516A1 Method for improving dissolution of poorly dispersible medicaments
05/15/2003WO2003039515A1 Process for preparing dry extracts
05/15/2003WO2003039514A1 Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
05/15/2003WO2003039513A1 Method for the formation of ibuprofen crystals
05/15/2003WO2003039512A1 Liposomal formulations and related methods
05/15/2003WO2003039511A1 New use of ethoxylated phytosterols and phytostanols
05/15/2003WO2003039510A1 Compositions containing oils having a specific gravity higher than the specific gravity of water
05/15/2003WO2003039488A2 A method for treating inflammatory bowel disease
05/15/2003WO2003039485A2 Stable liquid pharmaceutical formulation of igg antibodies
05/15/2003WO2003039472A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003WO2003039465A2 Treating canker sores with patches to speed healing and relieve pain
05/15/2003WO2003039464A2 Antimuscarinic aerosol
05/15/2003WO2003039452A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003WO2003039444A2 Topical use of cytokines and/or chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
05/15/2003WO2003039437A2 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel
05/15/2003WO2003039436A2 Pharmaceutical compositions containing oxybutynin
05/15/2003WO2003039435A2 Process of obtaining colloidal dispersions of amphotercin b; compounds based on amphothericine b for enteral, paraenteral and topical use; use of these compounds in the treatment of systemic mycoses and parasitic infections
05/15/2003WO2003039434A2 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof
05/15/2003WO2003039418A1 Compositions for the treatment of infectious diseases
05/15/2003WO2003039382A2 System for processing tissue
05/15/2003WO2003039331A2 Method for improving stability of a bone-connecting implant
05/15/2003WO2003039273A1 Molecular press dehydration method for vegetative tissue using the solid phase of water soluble polymer substances as a dehydrating agent
05/15/2003WO2003006063A3 Formulation comprising fulvestrant
05/15/2003WO2003000692A3 Oxytocin agonists
05/15/2003WO2002100342A3 (s, s'), (s, r')-amphetaminil, compositions and uses thereof
05/15/2003WO2002094316A3 Method of preparing aluminium-hydroxide gel
05/15/2003WO2002088318A3 Lipid-comprising drug delivery complexes and methods for their production
05/15/2003WO2002083926A3 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
05/15/2003WO2002067961A3 Therapeutic uses of herbal compositions
05/15/2003WO2002064046A3 A compound and method of treatment for fungal pathologies of the oral cavity
05/15/2003WO2002049620A3 Induced phase transition method for the production of microparticles containing hydrophobic active agents
05/15/2003WO2002045573A8 Condom with male genital desensitizer lubricant
05/15/2003WO2002038208A3 Device and method for the cessation of smoking
05/15/2003WO2002030392A3 Formulation containing amoxicillin
05/15/2003WO2002029031A3 Isoprenoid-dependent ras anchorage (idra) proteins
05/15/2003WO2002017888A9 Controlled and sustained release properties of polyelectrolyte multilayer capsules
05/15/2003WO2001080832A3 Administration of a thiol-based chemoprotectant compound
05/15/2003WO2001022791A8 Controlled release compositions comprising nimesulide
05/15/2003US20030093157 Biocompatible,bulking agent or implant that degrades slowly under biological conditions, is hypoallergenic, non-migratory, relatively inexpensive and simple to apply; for therapy of congenital anomaly, a scar or a wrinkle
05/15/2003US20030093063 Valve for osmotic devices
05/15/2003US20030093062 Method and apparatus for treating a patient
05/15/2003US20030092776 Drug mixed with polymeric carrier; bioavailability; ethylene oxide-propylene oxide copolymer; film forming
05/15/2003US20030092774 In situ administering; iontophoresis; for eyes, joints
05/15/2003US20030092764 Oxidation resistance
05/15/2003US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
05/15/2003US20030092724 Multilayer dosage form
05/15/2003US20030092691 Pharmaceutical composition based on micronized progesterone, method for the preparation thereof and uses thereof
05/15/2003US20030092690 Administering by inhalation
05/15/2003US20030092672 Amphiphilic macrocyclic derivatives and their analogues
05/15/2003US20030092669 Method for normalizing insulin levels
05/15/2003US20030092666 Compositions and methods for nucleic acid delivery to the lung
05/15/2003US20030092655 Delivery system for nucleic acids
05/15/2003US20030092640 Water, azalide compound, 25-75% propylene glycol, and acids
05/15/2003US20030092635 Galenical preparations of dapsone and related sulphones, and method of therapeutic and preventative treatment of disease
05/15/2003US20030092630 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases
05/15/2003US20030092625 Aqueous prolonged release formulation
05/15/2003US20030092622 Preparation stabilized over long time
05/15/2003US20030092612 Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
05/15/2003US20030092607 A stable antibody liquid comprising a precipitated immunoglobulins and water; precipitating with a biocompatible polymer; storage stability
05/15/2003US20030092606 Formulations for amylin agonist peptides
05/15/2003US20030092163 Probiotic bifidobacterium strains
05/15/2003US20030092130 DNA encoding polypeptides having interferon-gamma inducing activity
05/15/2003US20030092069 Hollow nanoparticle for use in the transfer of biopolymer into cells
05/15/2003US20030092043 Melanoma differentiation associated gene - 5 and promoter and uses thereof
05/15/2003US20030091974 Detecting compounds capable of exhausting mast cells; culture mast cells, incubate with modulator, measure mast cell death, classify compound
05/15/2003US20030091725 Method for treating particulate material with a coating medium and an apparatus for carrying out the method
1 ... 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 ... 2991